What is the projected market valuation of the Point of Care Diagnostics Testing Market by 2035?

The market is projected to reach approximately 157.87 USD Billion by 2035. Read More

What was the market valuation of the Point of Care Diagnostics Testing Market in 2024?

The market valuation was 57.71 USD Billion in 2024. Read More

What is the expected CAGR for the market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 9.58%. Read More

Which segment is projected to have the highest valuation in the market by 2035?

The Homecare/Self Testing segment is projected to reach approximately 63.87 USD Billion by 2035. Read More

What are the key players in the Point of Care Diagnostics Testing Market?

Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Danaher Corporation. Read More

How does the valuation of Infectious Disease Testing compare to other segments in 2035?

Infectious Disease Testing is projected to reach around 30.0 USD Billion, indicating strong growth relative to other segments. Read More

What is the projected valuation for Prescription-based testing products by 2035?

Prescription-based testing products are expected to reach approximately 95.51 USD Billion by 2035. Read More

Which platform segment is anticipated to show significant growth by 2035?

Molecular Diagnostics is anticipated to grow significantly, reaching about 70.0 USD Billion by 2035. Read More

What is the expected valuation for the Coagulation Monitoring segment by 2035?

The Coagulation Monitoring segment is projected to reach approximately 12.0 USD Billion by 2035. Read More

How does the market for OTC Testing Products compare to Prescription-based testing products in 2035?

OTC Testing Products are projected to reach around 62.36 USD Billion, while Prescription-based testing products are expected to reach 95.51 USD Billion by 2035. Read More

Point of Care Diagnostics Testing Market

ID: MRFR/HC/9161-HCR

120 Pages

Rahul Gotadki

Last Updated: May 15, 2026

Point of Care Diagnostics Testing Market Research Report: Size, Share, Trend Analysis By Product (Glucose Monitoring, Cardiometabolic Monitoring, Infectious Disease Testing, Coagulation Monitoring, Pregnancy & Fertility Testing, Hematology Testing, Cancer/Tumor Marker Testing, Urinalysis Testing, Cholesterol, Drugs-of-Abuse Testing), By End User (Hospitals & Clinics, Diagnostic Centers, Homecare/Self Testing), By Mode of Purchase (OTC, Prescription-based), By Platform (Immunoassays, Molecular Diagnostics, Dipsticks), and Region - Growth Outlook & Industry Forecast 2025 To 2035

Point of Care Diagnostics Testing Market Infographic

Summary Table of Contents Segmentation Methodology Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Product (USD Billion) | |
  1. 4.1.1 Glucose Monitoring | |
  2. 4.1.2 Cardiometabolic Monitoring | |
  3. 4.1.3 Infectious Disease Testing | |
  4. 4.1.4 Coagulation Monitoring | |
  5. 4.1.5 Pregnancy & Fertility Testing | |
  6. 4.1.6 Hematology Testing | |
  7. 4.1.7 Cancer/Tumor Marker Testing | |
  8. 4.1.8 Urinalysis Testing | |
  9. 4.1.9 Cholesterol | |
  10. 4.1.10 Drugs-of-Abuse Testing |
2. 4.2 Healthcare, BY End User (USD Billion) | |
  1. 4.2.1 Hospitals & Clinics | |
  2. 4.2.2 Diagnostic Centers | |
  3. 4.2.3 Homecare/Self Testing |
3. 4.3 Healthcare, BY Mode of Purchase (USD Billion) | |
  1. 4.3.1 OTC Testing Products | |
  2. 4.3.2 Prescription-based testing products |
4. 4.4 Healthcare, BY Platform (USD Billion) | |
  1. 4.4.1 Immunoassays | |
  2. 4.4.2 Molecular Diagnostics | |
  3. 4.4.3 Dipsticks |
5. 4.5 Healthcare, BY Region (USD Billion) | |
  1. 4.5.1 North America | | |
    1. 4.5.1.1 US | | |
    2. 4.5.1.2 Canada | |
  2. 4.5.2 Europe | | |
    1. 4.5.2.1 Germany | | |
    2. 4.5.2.2 UK | | |
    3. 4.5.2.3 France | | |
    4. 4.5.2.4 Russia | | |
    5. 4.5.2.5 Italy | | |
    6. 4.5.2.6 Spain | | |
    7. 4.5.2.7 Rest of Europe | |
  3. 4.5.3 APAC | | |
    1. 4.5.3.1 China | | |
    2. 4.5.3.2 India | | |
    3. 4.5.3.3 Japan | | |
    4. 4.5.3.4 South Korea | | |
    5. 4.5.3.5 Malaysia | | |
    6. 4.5.3.6 Thailand | | |
    7. 4.5.3.7 Indonesia | | |
    8. 4.5.3.8 Rest of APAC | |
  4. 4.5.4 South America | | |
    1. 4.5.4.1 Brazil | | |
    2. 4.5.4.2 Mexico | | |
    3. 4.5.4.3 Argentina | | |
    4. 4.5.4.4 Rest of South America | |
  5. 4.5.5 MEA | | |
    1. 4.5.5.1 GCC Countries | | |
    2. 4.5.5.2 South Africa | | |
    3. 4.5.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Abbott Laboratories (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Roche Diagnostics (CH) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Siemens Healthineers (DE) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Danaher Corporation (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Thermo Fisher Scientific (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Becton Dickinson and Company (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Cepheid (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Quidel Corporation (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Hologic, Inc. (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY PRODUCT |
7. 6.4 US MARKET ANALYSIS BY END USER |
8. 6.5 US MARKET ANALYSIS BY MODE OF PURCHASE |
9. 6.6 US MARKET ANALYSIS BY PLATFORM |
10. 6.7 CANADA MARKET ANALYSIS BY PRODUCT |
11. 6.8 CANADA MARKET ANALYSIS BY END USER |
12. 6.9 CANADA MARKET ANALYSIS BY MODE OF PURCHASE |
13. 6.10 CANADA MARKET ANALYSIS BY PLATFORM |
14. 6.11 EUROPE MARKET ANALYSIS |
15. 6.12 GERMANY MARKET ANALYSIS BY PRODUCT |
16. 6.13 GERMANY MARKET ANALYSIS BY END USER |
17. 6.14 GERMANY MARKET ANALYSIS BY MODE OF PURCHASE |
18. 6.15 GERMANY MARKET ANALYSIS BY PLATFORM |
19. 6.16 UK MARKET ANALYSIS BY PRODUCT |
20. 6.17 UK MARKET ANALYSIS BY END USER |
21. 6.18 UK MARKET ANALYSIS BY MODE OF PURCHASE |
22. 6.19 UK MARKET ANALYSIS BY PLATFORM |
23. 6.20 FRANCE MARKET ANALYSIS BY PRODUCT |
24. 6.21 FRANCE MARKET ANALYSIS BY END USER |
25. 6.22 FRANCE MARKET ANALYSIS BY MODE OF PURCHASE |
26. 6.23 FRANCE MARKET ANALYSIS BY PLATFORM |
27. 6.24 RUSSIA MARKET ANALYSIS BY PRODUCT |
28. 6.25 RUSSIA MARKET ANALYSIS BY END USER |
29. 6.26 RUSSIA MARKET ANALYSIS BY MODE OF PURCHASE |
30. 6.27 RUSSIA MARKET ANALYSIS BY PLATFORM |
31. 6.28 ITALY MARKET ANALYSIS BY PRODUCT |
32. 6.29 ITALY MARKET ANALYSIS BY END USER |
33. 6.30 ITALY MARKET ANALYSIS BY MODE OF PURCHASE |
34. 6.31 ITALY MARKET ANALYSIS BY PLATFORM |
35. 6.32 SPAIN MARKET ANALYSIS BY PRODUCT |
36. 6.33 SPAIN MARKET ANALYSIS BY END USER |
37. 6.34 SPAIN MARKET ANALYSIS BY MODE OF PURCHASE |
38. 6.35 SPAIN MARKET ANALYSIS BY PLATFORM |
39. 6.36 REST OF EUROPE MARKET ANALYSIS BY PRODUCT |
40. 6.37 REST OF EUROPE MARKET ANALYSIS BY END USER |
41. 6.38 REST OF EUROPE MARKET ANALYSIS BY MODE OF PURCHASE |
42. 6.39 REST OF EUROPE MARKET ANALYSIS BY PLATFORM |
43. 6.40 APAC MARKET ANALYSIS |
44. 6.41 CHINA MARKET ANALYSIS BY PRODUCT |
45. 6.42 CHINA MARKET ANALYSIS BY END USER |
46. 6.43 CHINA MARKET ANALYSIS BY MODE OF PURCHASE |
47. 6.44 CHINA MARKET ANALYSIS BY PLATFORM |
48. 6.45 INDIA MARKET ANALYSIS BY PRODUCT |
49. 6.46 INDIA MARKET ANALYSIS BY END USER |
50. 6.47 INDIA MARKET ANALYSIS BY MODE OF PURCHASE |
51. 6.48 INDIA MARKET ANALYSIS BY PLATFORM |
52. 6.49 JAPAN MARKET ANALYSIS BY PRODUCT |
53. 6.50 JAPAN MARKET ANALYSIS BY END USER |
54. 6.51 JAPAN MARKET ANALYSIS BY MODE OF PURCHASE |
55. 6.52 JAPAN MARKET ANALYSIS BY PLATFORM |
56. 6.53 SOUTH KOREA MARKET ANALYSIS BY PRODUCT |
57. 6.54 SOUTH KOREA MARKET ANALYSIS BY END USER |
58. 6.55 SOUTH KOREA MARKET ANALYSIS BY MODE OF PURCHASE |
59. 6.56 SOUTH KOREA MARKET ANALYSIS BY PLATFORM |
60. 6.57 MALAYSIA MARKET ANALYSIS BY PRODUCT |
61. 6.58 MALAYSIA MARKET ANALYSIS BY END USER |
62. 6.59 MALAYSIA MARKET ANALYSIS BY MODE OF PURCHASE |
63. 6.60 MALAYSIA MARKET ANALYSIS BY PLATFORM |
64. 6.61 THAILAND MARKET ANALYSIS BY PRODUCT |
65. 6.62 THAILAND MARKET ANALYSIS BY END USER |
66. 6.63 THAILAND MARKET ANALYSIS BY MODE OF PURCHASE |
67. 6.64 THAILAND MARKET ANALYSIS BY PLATFORM |
68. 6.65 INDONESIA MARKET ANALYSIS BY PRODUCT |
69. 6.66 INDONESIA MARKET ANALYSIS BY END USER |
70. 6.67 INDONESIA MARKET ANALYSIS BY MODE OF PURCHASE |
71. 6.68 INDONESIA MARKET ANALYSIS BY PLATFORM |
72. 6.69 REST OF APAC MARKET ANALYSIS BY PRODUCT |
73. 6.70 REST OF APAC MARKET ANALYSIS BY END USER |
74. 6.71 REST OF APAC MARKET ANALYSIS BY MODE OF PURCHASE |
75. 6.72 REST OF APAC MARKET ANALYSIS BY PLATFORM |
76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
77. 6.74 BRAZIL MARKET ANALYSIS BY PRODUCT |
78. 6.75 BRAZIL MARKET ANALYSIS BY END USER |
79. 6.76 BRAZIL MARKET ANALYSIS BY MODE OF PURCHASE |
80. 6.77 BRAZIL MARKET ANALYSIS BY PLATFORM |
81. 6.78 MEXICO MARKET ANALYSIS BY PRODUCT |
82. 6.79 MEXICO MARKET ANALYSIS BY END USER |
83. 6.80 MEXICO MARKET ANALYSIS BY MODE OF PURCHASE |
84. 6.81 MEXICO MARKET ANALYSIS BY PLATFORM |
85. 6.82 ARGENTINA MARKET ANALYSIS BY PRODUCT |
86. 6.83 ARGENTINA MARKET ANALYSIS BY END USER |
87. 6.84 ARGENTINA MARKET ANALYSIS BY MODE OF PURCHASE |
88. 6.85 ARGENTINA MARKET ANALYSIS BY PLATFORM |
89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT |
90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY MODE OF PURCHASE |
92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY PLATFORM |
93. 6.90 MEA MARKET ANALYSIS |
94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT |
95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY END USER |
96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY MODE OF PURCHASE |
97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY PLATFORM |
98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT |
99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY END USER |
100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY MODE OF PURCHASE |
101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY PLATFORM |
102. 6.99 REST OF MEA MARKET ANALYSIS BY PRODUCT |
103. 6.100 REST OF MEA MARKET ANALYSIS BY END USER |
104. 6.101 REST OF MEA MARKET ANALYSIS BY MODE OF PURCHASE |
105. 6.102 REST OF MEA MARKET ANALYSIS BY PLATFORM |
106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
107. 6.104 RESEARCH PROCESS OF MRFR |
108. 6.105 DRO ANALYSIS OF HEALTHCARE |
109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
112. 6.109 HEALTHCARE, BY PRODUCT, 2024 (% SHARE) |
113. 6.110 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Billion) |
114. 6.111 HEALTHCARE, BY END USER, 2024 (% SHARE) |
115. 6.112 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
116. 6.113 HEALTHCARE, BY MODE OF PURCHASE, 2024 (% SHARE) |
117. 6.114 HEALTHCARE, BY MODE OF PURCHASE, 2024 TO 2035 (USD Billion) |
118. 6.115 HEALTHCARE, BY PLATFORM, 2024 (% SHARE) |
119. 6.116 HEALTHCARE, BY PLATFORM, 2024 TO 2035 (USD Billion) |
120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
121. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY PLATFORM, 2025-2035 (USD Billion) |
123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY PLATFORM, 2025-2035 (USD Billion) |
124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY PLATFORM, 2025-2035 (USD Billion) |
125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY PLATFORM, 2025-2035 (USD Billion) |
126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY PLATFORM, 2025-2035 (USD Billion) |
127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY PLATFORM, 2025-2035 (USD Billion) |
128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY PLATFORM, 2025-2035 (USD Billion) |
129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY PLATFORM, 2025-2035 (USD Billion) |
130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY PLATFORM, 2025-2035 (USD Billion) |
131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY PLATFORM, 2025-2035 (USD Billion) |
132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY PLATFORM, 2025-2035 (USD Billion) |
133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY PLATFORM, 2025-2035 (USD Billion) |
134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY PLATFORM, 2025-2035 (USD Billion) |
135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY PLATFORM, 2025-2035 (USD Billion) |
136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY PLATFORM, 2025-2035 (USD Billion) |
137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY PLATFORM, 2025-2035 (USD Billion) |
138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY PLATFORM, 2025-2035 (USD Billion) |
139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY PLATFORM, 2025-2035 (USD Billion) |
140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY PLATFORM, 2025-2035 (USD Billion) |
141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY PLATFORM, 2025-2035 (USD Billion) |
142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY PLATFORM, 2025-2035 (USD Billion) |
143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY PLATFORM, 2025-2035 (USD Billion) |
144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY PLATFORM, 2025-2035 (USD Billion) |
145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY PLATFORM, 2025-2035 (USD Billion) |
146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY PLATFORM, 2025-2035 (USD Billion) |
147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY PLATFORM, 2025-2035 (USD Billion) |
148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY PLATFORM, 2025-2035 (USD Billion) |
149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY PLATFORM, 2025-2035 (USD Billion) |
150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY PRODUCT, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY END USER, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY MODE OF PURCHASE, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY PLATFORM, 2025-2035 (USD Billion) |
151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
152. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Product (USD Billion, 2025-2035)

Glucose Monitoring
Cardiometabolic Monitoring
Infectious Disease Testing
Coagulation Monitoring
Pregnancy & Fertility Testing
Hematology Testing
Cancer/Tumor Marker Testing
Urinalysis Testing
Cholesterol
Drugs-of-Abuse Testing

Healthcare By End User (USD Billion, 2025-2035)

Hospitals & Clinics
Diagnostic Centers
Homecare/Self Testing

Healthcare By Mode of Purchase (USD Billion, 2025-2035)

OTC Testing Products
Prescription-based testing products

Healthcare By Platform (USD Billion, 2025-2035)

Immunoassays
Molecular Diagnostics
Dipsticks

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓